2013 – Innovation Days One of 15 finalists « Innovation Prize » Universal Biotech.
Regulaxis is proud to present the recent results on the effectiveness of REG-O3 in a model of traumatic knee osteoarthitis.
ACCEPTED POSTER :
« REG-O3, new chimeric peptides regulating IGF-1 pathway: significant therapeutic effect on ACLT rabbit model of osteoarthritis »
Raffaello PAOLINI, Rodrick MONTJEAN and Christelle VETU
Leave A Comment